ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
17.26
+0.48 (2.86%)
Jun 25, 2025, 4:00 PM - Market closed
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $1.70 billion as of June 26, 2025. Its market cap has increased by 98.58% in one year.
Market Cap
1.70B
Enterprise Value
1.49B
1-Year Change
98.58%
Ranking
Category
Stock Price
$17.26
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $1.70B, an increase of 198.31%. That is a compound annual growth rate of 51.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2025 | 1.70B | 65.33% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 693.14B |
| Johnson & Johnson | 362.21B |
| Novo Nordisk | 326.28B |
| AbbVie | 323.83B |
| UnitedHealth Group | 272.36B |
| Abbott Laboratories | 231.15B |
| Novartis AG | 229.25B |
| AstraZeneca | 217.06B |